Simplify Asset Management’s Pacira BioSciences PCRX Stock Holding History

Simplify Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Buy	83,083 +20,430	+33%	+$483K	0.03%	59
2026 Q1	$1.42M	Sell	62,653 -23,608	-27%	-$525K	0.02%	65
2025 Q4	$2.23M	Buy	86,261 +41,315	+92%	+$982K	0.04%	61
2025 Q3	$1.16M	Sell	44,946 -75,897	-63%	-$1.86M	0.02%	77
2025 Q2	$2.89M	Sell	120,843 -13,199	-10%	-$333K	0.15%	34
2025 Q1	$3.33M	Buy	134,042 +96,300	+255%	+$2.31M	0.12%	32
2024 Q4	$711K	Buy	+37,742	New	+$663K	0.04%	73

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplify Asset Management's PCRX Position: Q2 2026 in Review

Simplify Asset Management increased its Pacira BioSciences (PCRX) stake by 33% in Q2 2026, buying an estimated $483K and bringing the position to 83,083 shares worth $2.11M. The position accounts for 0.03% of the portfolio, ranked #59.

Simplify Asset Management first reported a position in PCRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.33M in Q1 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Simplify Asset Management held 83,083 shares of Pacira BioSciences worth $2.11M as of Q2 2026.
Simplify Asset Management bought 20,430 Pacira BioSciences shares in Q2 2026, an estimated $483K.
Pacira BioSciences made up 0.03% of Simplify Asset Management's portfolio in Q2 2026, its #59 holding.
Simplify Asset Management first reported a position in Pacira BioSciences in Q4 2024 and has held it in 7 quarters since.
Simplify Asset Management's Pacira BioSciences position peaked at $3.33M in Q1 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.